Works matching AU Ahn, Jin Seok


Results: 175
    1
    2
    3
    4
    5
    6

    A phase II trial of the pan‐HER inhibitor poziotinib, in patients with HER2‐positive metastatic breast cancer who had received at least two prior HER2‐directed regimens: results of the NOV120101‐203 trial.

    Published in:
    International Journal of Cancer, 2018, v. 143, n. 12, p. 3240, doi. 10.1002/ijc.31651
    By:
    • Park, Yeon Hee;
    • Lee, Kyung‐Hun;
    • Sohn, Joo Hyuk;
    • Lee, Keun Seok;
    • Jung, Kyung Hae;
    • Kim, Jee‐Hyun;
    • Lee, Ki Hyeong;
    • Ahn, Jin Seok;
    • Kim, Tae‐Yong;
    • Kim, Gun Min;
    • Park, In Hae;
    • Kim, Sung‐Bae;
    • Kim, Se Hyun;
    • Han, Hye Sook;
    • Im, Young‐Hyuck;
    • Ahn, Jin‐Hee;
    • Kim, Jung‐Yong;
    • Kang, Jahoon;
    • Im, Seock‐Ah
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Phase IV study evaluating efficacy of escalated dose of imatinib in chronic myeloid leukemia patients showing suboptimal response to standard dose imatinib.

    Published in:
    Annals of Hematology, 2010, v. 89, n. 7, p. 725, doi. 10.1007/s00277-010-0910-8
    By:
    • Youngil Koh;
    • Inho Kim;
    • Sung-Soo Yoon;
    • Byoung Kook Kim;
    • Dae-Young Kim;
    • Je-Hwan Lee;
    • Kyoo-Hyung Lee;
    • Eunkyung Park;
    • Hyeoung-Joon Kim;
    • Sang Kyun Sohn;
    • Young Don Joo;
    • Seok Jin Kim;
    • Jooseop Chung;
    • Ho-Jin Shin;
    • Sung-Hyun Kim;
    • Chul Soo Kim;
    • Hong Suk Song;
    • Min Kyoung Kim;
    • Myung Soo Hyun;
    • Jin Seok Ahn
    Publication type:
    Article
    17

    Biomarker role of thyroid irAE and PD-L1 positivity in predicting PD-1 blockade efficacy in patients with non-small cell lung cancer.

    Published in:
    Cancer Immunology, Immunotherapy, 2024, v. 73, n. 12, p. 1, doi. 10.1007/s00262-024-03852-w
    By:
    • Kim, Hye In;
    • Kim, Won Gu;
    • Kim, Mijin;
    • Ko, Nak Gyeong;
    • Jin, Mihyeon;
    • Jung, Hyun Ae;
    • Sun, Jong-Mu;
    • Ahn, Jin Seok;
    • Ahn, Myung-Ju;
    • Choi, Yoon-La;
    • Jeon, Min Ji;
    • Kim, Tae Yong;
    • Kim, Won Bae;
    • Kim, Sang-We;
    • Lee, Dae Ho;
    • Jang, Se Jin;
    • Kim, Sun Wook;
    • Chung, Jae Hoon;
    • Kim, Tae Hyuk;
    • Lee, Se-Hoon
    Publication type:
    Article
    18

    Biomarker role of thyroid irAE and PD-L1 positivity in predicting PD-1 blockade efficacy in patients with non-small cell lung cancer.

    Published in:
    Cancer Immunology, Immunotherapy, 2024, v. 73, n. 12, p. 1, doi. 10.1007/s00262-024-03852-w
    By:
    • Kim, Hye In;
    • Kim, Won Gu;
    • Kim, Mijin;
    • Ko, Nak Gyeong;
    • Jin, Mihyeon;
    • Jung, Hyun Ae;
    • Sun, Jong-Mu;
    • Ahn, Jin Seok;
    • Ahn, Myung-Ju;
    • Choi, Yoon-La;
    • Jeon, Min Ji;
    • Kim, Tae Yong;
    • Kim, Won Bae;
    • Kim, Sang-We;
    • Lee, Dae Ho;
    • Jang, Se Jin;
    • Kim, Sun Wook;
    • Chung, Jae Hoon;
    • Kim, Tae Hyuk;
    • Lee, Se-Hoon
    Publication type:
    Article
    19
    20

    Phase 1b Trial of Ficlatuzumab, a Humanized Hepatocyte Growth Factor Inhibitory Monoclonal Antibody, in Combination With Gefitinib in Asian Patients With NSCLC.

    Published in:
    Clinical Pharmacology in Drug Development, 2018, v. 7, n. 5, p. 532, doi. 10.1002/cpdd.427
    By:
    • Tan, Eng‐Huat;
    • Lim, Wan‐Teck;
    • Ahn, Myung‐Ju;
    • Ng, Quan‐Sing;
    • Ahn, Jin Seok;
    • Shao‐Weng Tan, Daniel;
    • Sun, Jong‐Mu;
    • Han, May;
    • Payumo, Francis C.;
    • McKee, Krista;
    • Yin, Wei;
    • Credi, Marc;
    • Agarwal, Shefali;
    • Jac, Jaroslaw;
    • Park, Keunchil
    Publication type:
    Article
    21

    Multi-omics profiling of younger Asian breast cancers reveals distinctive molecular signatures.

    Published in:
    Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-04129-4
    By:
    • Zhengyan Kan;
    • Ying Ding;
    • Jinho Kim;
    • Hae Hyun Jung;
    • Woosung Chung;
    • Lal, Samir;
    • Soonweng Cho;
    • Fernandez-Banet, Julio;
    • Se Kyung Lee;
    • Seok Won Kim;
    • Jeong Eon Lee;
    • Yoon-La Choi;
    • Shibing Deng;
    • Ji-Yeon Kim;
    • Jin Seok Ahn;
    • Ying Sha;
    • Xinmeng Jasmine Mu;
    • Jae-Yong Nam;
    • Im, Young-Hyuck;
    • Soohyeon Lee
    Publication type:
    Article
    22

    Prevalence and detection of low-allele-fraction variants in clinical cancer samples.

    Published in:
    Nature Communications, 2017, v. 8, n. 1, p. 1, doi. 10.1038/s41467-017-01470-y
    By:
    • Hyun-Tae Shin;
    • Yoon-La Choi;
    • Jae Won Yun;
    • Kim, Nayoung K. D.;
    • Sook-Young Kim;
    • Hyo Jeong Jeon;
    • Jae-Yong Nam;
    • Chung Lee;
    • Daeun Ryu;
    • Sang Cheol Kim;
    • Kyunghee Park;
    • Eunjin Lee;
    • Joon Seol Bae;
    • Dae Soon Son;
    • Je-Gun Joung;
    • Jeeyun Lee;
    • Seung Tae Kim;
    • Myung-Ju Ahn;
    • Se-Hoon Lee;
    • Jin Seok Ahn
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45

    Long‐term effects of crizotinib in ALK‐positive tumors (excluding NSCLC): A phase 1b open‐label study.

    Published in:
    American Journal of Hematology, 2018, v. 93, n. 5, p. 607, doi. 10.1002/ajh.25043
    By:
    • Gambacorti‐Passerini, Carlo;
    • Orlov, Sergey;
    • Zhang, Li;
    • Braiteh, Fadi;
    • Huang, Huiqiang;
    • Esaki, Taito;
    • Horibe, Keizo;
    • Ahn, Jin‐Seok;
    • Beck, Joseph T.;
    • Edenfield, William Jeffrey;
    • Shi, Yuankai;
    • Taylor, Matthew;
    • Tamura, Kenji;
    • Van Tine, Brian A.;
    • Wu, Shang‐Ju;
    • Paolini, Jolanda;
    • Selaru, Paulina;
    • Kim, Tae Min
    Publication type:
    Article
    46
    47
    48
    49
    50